Substantial increase in centrally reported adverse reactions to Lareb

Lareb is the official Netherlands Pharmacovigilance Centre responsible for collecting and analyzing reports of adverse reactions of medicines and vaccines. According to Lareb the number of centrally reported adverse events increased by 11% in 2015, partly due to the automated forwarding of events in the online DREAM registry developed by TiH. Read the Lareb 2015 report here.